Stockreport

What Daiichi Sankyo Company (TSE:4568)'s ENHERTU EMA Filing and AI Oncology Push Mean For Shareholders [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF early-stage HER2 positive breast cancer, a new AI-focused collaboration with BostonGene in antibody drug conjugate development, board-level succession in global R&D lead [Read more]